Unit of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Amarjit Saini in
Google Scholar
PubMed
Search for other papers by Linda Björkhem-Bergman in
Google Scholar
PubMed
Unit of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Johan Boström in
Google Scholar
PubMed
Unit of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Mats Lilja in
Google Scholar
PubMed
Unit of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden
Unit of Cardiology, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Michael Melin in
Google Scholar
PubMed
Unit of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Karl Olsson in
Google Scholar
PubMed
Search for other papers by Lena Ekström in
Google Scholar
PubMed
Search for other papers by Peter Bergman in
Google Scholar
PubMed
Unit of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Mikael Altun in
Google Scholar
PubMed
Unit of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden
Unit of Cardiology, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Eric Rullman in
Google Scholar
PubMed
Unit of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Thomas Gustafsson in
Google Scholar
PubMed
), especially in patients with fibromyalgia ( 4 ) and has also been linked to an increased risk of statin-induced myalgia in two observational studies ( 5 , 6 ). It has been shown that old people and patients with 25-OHD concentrations of 46.3 ± 9.5 nmol/L have
Search for other papers by Ying-Lien Cheng in
Google Scholar
PubMed
Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Search for other papers by Ting-I Lee in
Google Scholar
PubMed
Search for other papers by Yu-Mei Chien in
Google Scholar
PubMed
Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Search for other papers by Ting-Wei Lee in
Google Scholar
PubMed
Cardiovascular Research Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan
Search for other papers by Yi-Jen Chen in
Google Scholar
PubMed
)D measurement, and had two 25(OH)D measurements less than 3 months or greater than 3 years apart ( Fig. 1 ). We collected data regarding patient characteristics, such as age, sex, body weight, body height, drug history (e.g., statin, fibric acids, nicotinic acid
Search for other papers by Panagiotis Anagnostis in
Google Scholar
PubMed
Search for other papers by Irene Lambrinoudaki in
Google Scholar
PubMed
Search for other papers by John C Stevenson in
Google Scholar
PubMed
Search for other papers by Dimitrios G Goulis in
Google Scholar
PubMed
.e. statins, ezetimibe) when necessary ( 39 ). Regarding the progestogen, priority should be given to micronized progesterone or dydrogesterone, due to their neutral effect on lipid profile ( 39 ). Assessment of CVD risk in postmenopausal women In
Clinical Cooperation Group Diabetes, LMU München and Helmholtz Zentrum München, Munich, Germany
Search for other papers by Cornelia Then in
Google Scholar
PubMed
Search for other papers by Holger Then in
Google Scholar
PubMed
Clinical Cooperation Group Diabetes, LMU München and Helmholtz Zentrum München, Munich, Germany
German Center for Diabetes Research (DZD), München-Neuherberg, Germany
Search for other papers by Andreas Lechner in
Google Scholar
PubMed
Institute of Epidemiology, Helmholtz Zentrum München – German Research Center for Environmental Health (GmbH), Neuherberg, Germany
Search for other papers by Cornelia Huth in
Google Scholar
PubMed
Chair of Epidemiology at UNIKAT Augsburg, Ludwig-Maximilians-Universität München, Munich, Germany
Search for other papers by Christa Meisinger in
Google Scholar
PubMed
KORA Study Center, University Hospital Augsburg, Augsburg, Germany
Search for other papers by Margit Heier in
Google Scholar
PubMed
Institute of Epidemiology, Helmholtz Zentrum München – German Research Center for Environmental Health (GmbH), Neuherberg, Germany
DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
Search for other papers by Annette Peters in
Google Scholar
PubMed
Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany
Deutsches Herzzentrum München, Technische Universität München, Munich, Germany
Search for other papers by Wolfgang Koenig in
Google Scholar
PubMed
Search for other papers by Wolfgang Rathmann in
Google Scholar
PubMed
Institute of Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Search for other papers by Christian Herder in
Google Scholar
PubMed
Institute of Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Search for other papers by Michael Roden in
Google Scholar
PubMed
Search for other papers by Jürgen Scherberich in
Google Scholar
PubMed
Clinical Cooperation Group Diabetes, LMU München and Helmholtz Zentrum München, Munich, Germany
Search for other papers by Jochen Seissler in
Google Scholar
PubMed
4: Model 3 plus hsCRP (log-transformed, continuous); Model 5: Model 4 plus arterial hypertension (yes/no) and fasting glucose (continuous); Model 6: Model 5 plus BMI (continuous) and treatment with statins and fibrates (yes/no, respectively). Model 1
Department of Medical Sciences, Occupational and Environmental Medicine, Uppsala University, Uppsala, Sweden
Search for other papers by Johanna Christina Penell in
Google Scholar
PubMed
ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA
Search for other papers by Mark M Kushnir in
Google Scholar
PubMed
Search for other papers by Lars Lind in
Google Scholar
PubMed
Search for other papers by Jonatan Bergquist in
Google Scholar
PubMed
Department of Chemistry – BMC, Analytical Chemistry, Uppsala University, Uppsala, Sweden
Search for other papers by Jonas Bergquist in
Google Scholar
PubMed
Search for other papers by P Monica Lind in
Google Scholar
PubMed
Search for other papers by Tord Naessen in
Google Scholar
PubMed
treatment was defined as the current treatment with statins or other lipid-lowering medication. Common cardiovascular disease-related drugs were defined as any regular pharmaceutical treatment. All participants were investigated in the morning after an over
Department of Diabetes and Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by B Shahida in
Google Scholar
PubMed
Department of Clinical Sciences, Lund University, Malmö, Sweden
Search for other papers by P Sahlstrand Johnson in
Google Scholar
PubMed
Search for other papers by R Jain in
Google Scholar
PubMed
Department of Plastic Surgery, Skåne University Hospital, Malmö, Sweden
Search for other papers by H Brorson in
Google Scholar
PubMed
Department of Ophthalmology, Skåne University Hospital, Malmö, Sweden
Search for other papers by P Åsman in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by M Lantz in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by T Planck in
Google Scholar
PubMed
in osteoblasts ( 16 ) and synovial fibroblasts ( 17 ). In newly diagnosed GD patients, the use of statins significantly reduced the risk of development of GO ( 18 ). Based on the results of our expression studies from patients with GO, the aim of
Search for other papers by David J F Smith in
Google Scholar
PubMed
Search for other papers by Hemanth Prabhudev in
Google Scholar
PubMed
Department of Clinical Biochemistry, Imperial College Healthcare NHS Trust, London, UK
Department of Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK
Search for other papers by Sirazum Choudhury in
Google Scholar
PubMed
Department of Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK
Search for other papers by Karim Meeran in
Google Scholar
PubMed
anti-hypertensives or statins was similar between the two groups, as were diagnoses of diabetes and hypertension. The proportion of patients with primary AI vs secondary AI was equivalent in both treatment groups. The mean total daily cumulative dose of
Search for other papers by V G Pluimakers in
Google Scholar
PubMed
Search for other papers by M van Waas in
Google Scholar
PubMed
Search for other papers by C W N Looman in
Google Scholar
PubMed
Search for other papers by M P de Maat in
Google Scholar
PubMed
Search for other papers by R de Jonge in
Google Scholar
PubMed
Search for other papers by P Delhanty in
Google Scholar
PubMed
Search for other papers by M Huisman in
Google Scholar
PubMed
Search for other papers by F U S Mattace-Raso in
Google Scholar
PubMed
Search for other papers by M M van den Heuvel-Eibrink in
Google Scholar
PubMed
Section Endocrinology, Department of Medicine, Erasmus MC, Rotterdam, The Netherlands
Search for other papers by S J C M M Neggers in
Google Scholar
PubMed
records. Detailed data regarding surgery were confirmed from the original surgical and pathological reports. Information on medication use (statins, antidiabetic, antihypertensive), smoking and socio-economic status was collected using a self
Search for other papers by Stephen J Winters in
Google Scholar
PubMed
Search for other papers by Charles R Scoggins in
Google Scholar
PubMed
Search for other papers by Duke Appiah in
Google Scholar
PubMed
Search for other papers by Dushan T Ghooray in
Google Scholar
PubMed
statins are indicated by open circles. Insulin resistance by HOMA-IR was found in the absence or presence of steatosis, whereas total lipid levels were low with insulin sensitivity. Table 2 Hepatic fatty acid composition, and HNF4α and SHBG
Search for other papers by Cheryl M Isherwood in
Google Scholar
PubMed
Search for other papers by M Denise Robertson in
Google Scholar
PubMed
Search for other papers by Debra J Skene in
Google Scholar
PubMed
Search for other papers by Jonathan D Johnston in
Google Scholar
PubMed
lean group was a smoker and was required to refrain from smoking for 1 week before the study. Two T2D participants were diet and exercise controlled (no medication) and five participants were treated with combinations of metformin, statins, ramipril and